Karent P. Brodscholl

Karent P. Brodscholl currently serves as the Director of Development Program Management at Genmab, a position held since October 2021. Prior experience includes directing Global Program & Portfolio Management for Autoimmune and Rare Diseases at Mallinckrodt Pharmaceuticals from November 2016 to September 2021, and various roles at Eisai US from January 2004 to August 2016, including Associate Director of R&D Program Management. Additional experience encompasses management positions at Bracco Diagnostics, Pfizer, the Harvard Clinical Research Institute, and Brigham and Women's Hospital. Karent holds a B.A. in Philosophy, Politics, and Law, as well as Italian Language and Literature from Binghamton University, and a Master of Public Health from Boston University School of Public Health.